Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: May 4, 2024
Date Accepted: Apr 15, 2025

The final, peer-reviewed published version of this preprint can be found here:

Impact of mHealth on Postoperative Quality of Life, Self-Management, and Dysfunction in Patients With Oral and Maxillofacial Tumors: Nonrandomized Controlled Trial

Li Y, Wang Y, Wu Y, Yu H, Yao H, Wang Y, Yin Y, Wang L, Hou L

Impact of mHealth on Postoperative Quality of Life, Self-Management, and Dysfunction in Patients With Oral and Maxillofacial Tumors: Nonrandomized Controlled Trial

JMIR Mhealth Uhealth 2025;13:e59926

DOI: 10.2196/59926

PMID: 40561502

PMCID: 12242703

Impact of mHealth on postoperative quality of life, self-management, and dysfunction in patients with oral and maxillofacial tumors: Multicenter Prospective Controlled Trial

  • Yufei Li; 
  • Yueping Wang; 
  • Yifan Wu; 
  • Hong Yu; 
  • Hua Yao; 
  • Yuqun Wang; 
  • Yulan Yin; 
  • Lan Wang; 
  • Lili Hou

ABSTRACT

Background:

With a focus on postoperative dysfunctions that may occur after maxillofacial tumor resection and the difficulties faced during home rehabilitation, we developed a mobile health application based on nurse-patient cooperation. The application extends rehabilitation care from hospital to home with the help of artificial intelligence, Internet of Things, and other technologies, thus helping patients to better carry out their home functional rehabilitation and meet their health needs.

Objective:

To assess changes in the quality of life, self-management efficacy, and functional impairment in patients with oral and maxillofacial tumours after receiving intervention from the Intelligent Home Rehabilitation Care Platform.

Methods:

In this quasi-experimental study, patients with oral and maxillofacial head and neck tumors who had undergone surgery were recruited from allied hospitals in the Yangtze River Delta region, divided into an experimental group (n=138) and a control group (n=123), and received either the Intelligent Home Rehabilitation Care Platform intervention or conventional healthcare and guidance, respectively. The intervention lasted 3 months, and the patients' quality of life, self-management efficacy, and improvement in dysfunction were assessed at 1 week, 1 month, and 3 months postoperatively.

Results:

Compared with the control group, the experimental group demonstrated significantly improved quality of life at 3 months postoperatively (287.55 vs 342.59 P<.05) and significantly improved self-management efficacy at 1 and 3 months postoperatively(P<.05). The experimental group showed improvements in shoulder function, dysphagia, and trismus after mHealth intervention; however, the differences were not significant.

Conclusions:

With a focus on postoperative dysfunctions that may occur after maxillofacial tumor resection and the difficulties faced during home rehabilitation, we developed a mobile health application based on nurse-patient cooperation. The application extends rehabilitation care from hospital to home with the help of artificial intelligence, Internet of Things, and other technologies, thus helping patients to better carry out their home functional rehabilitation and meet their health needs. The Intelligent Home Rehabilitation Care Platform interventions can effectively enhance patients' self-management efficacy and facilitate recovery from dysfunctions. Therefore, mHealth may be used in oncology care to provide smarter home self-care for patients. Clinical Trial: Chinese Clinical Trial Registry (ChiCTR2300073518)


 Citation

Please cite as:

Li Y, Wang Y, Wu Y, Yu H, Yao H, Wang Y, Yin Y, Wang L, Hou L

Impact of mHealth on Postoperative Quality of Life, Self-Management, and Dysfunction in Patients With Oral and Maxillofacial Tumors: Nonrandomized Controlled Trial

JMIR Mhealth Uhealth 2025;13:e59926

DOI: 10.2196/59926

PMID: 40561502

PMCID: 12242703

The author of this paper has made a PDF available, but requires the user to login, or create an account.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.